Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial

Published:2016-05-18 Issue:5 Volume:11 Page:e0154842
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Saxena Deepti,Spino Michael,Tricta Fernando,Connelly John,Cracchiolo Bernadette M.,Hanauske Axel-Rainer,D’Alliessi Gandolfi Darlene,Mathews Michael B.,Karn Jonathan,Holland Bart,Park Myung Hee,Pe’ery Tsafi,Palumbo Paul E.,Hanauske-Abel Hartmut M.

Funder

State of New Jersey Commission on Cancer Research

Pediatric AIDS Clinical Trials Group

NIH-NIAID (DoA)

NIH (BIRCWH)

National Institutes of Health

Foundation of UMDNJ

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference226 articles.

1. The challenge of HIV-1 subtype diversity;BS Taylor;N Engl J Med,2008

2. Variation of HIV-1 mutation spectra among cell types;CM Holtz;J Virol,2013

3. HIV-1 persistence in CD4 T cells with stem cell-like properties;MJ Buzon;Nat Med,2014

4. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management;AM Wensing;J Infect Dis,2005

5. Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission;JT Herbeck;AIDS,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting;PLOS ONE;2023-12-20

2. Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs;International Journal of Molecular Sciences;2023-11-25

3. Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial;Trials;2023-11-11

4. Lactate: A Theranostic Biomarker for Metabolic Psychiatry?;Antioxidants;2023-08-22

5. The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases;Pharmaceuticals;2023-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3